Literature DB >> 23588158

The Lambeth Conventions (II): guidelines for the study of animal and human ventricular and supraventricular arrhythmias.

Michael J Curtis1, Jules C Hancox, András Farkas, Cherry L Wainwright, Catherine L Stables, David A Saint, Hugh Clements-Jewery, Pier D Lambiase, George E Billman, Michiel J Janse, Michael K Pugsley, G André Ng, Dan M Roden, A John Camm, Michael J A Walker.   

Abstract

The 'Lambeth Conventions' is a guidance document, written in 1987 (Walker et al., 1988), intended to be of practical value in the investigation of experimental arrhythmias induced by ischaemia, infarction, and reperfusion. This is an update, expanded to include guidance on the study of supraventricular arrhythmias, drug-induced arrhythmias, heritable arrhythmias, and advances in our knowledge in core areas since 1987. We have updated the guidance on the design and execution of experiments and the definition, classification, quantification, and analysis of all types of arrhythmias. Investigators are encouraged to adopt the conventions and test their validity in the hope that this will improve uniformity and interlaboratory comparisons, aid clinical research, facilitate antiarrhythmic drug discovery and safety assessment, and improve antiarrhythmic drug deployment for different cardiac conditions. We note that there is a gap between some definitions proposed here and their conventional clinical counterparts, and encourage the research necessary to bridge that translational gap. A web link offers the chance to vote and comment on the new conventions (https://bscr.wufoo.com/forms/z7x0x5/).
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23588158     DOI: 10.1016/j.pharmthera.2013.04.008

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  93 in total

1.  Anti-arrhythmic effect of diosgenin in reperfusion-induced myocardial injury in a rat model: activation of nitric oxide system and mitochondrial KATP channel.

Authors:  Reza Badalzadeh; Bahman Yousefi; Maryam Majidinia; Hadi Ebrahimi
Journal:  J Physiol Sci       Date:  2014-08-24       Impact factor: 2.781

2.  Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System.

Authors:  Christiane Jungen; Katharina Scherschel; Nadja I Bork; Pawel Kuklik; Christian Eickholt; Helge Kniep; Niklas Klatt; Stephan Willems; Viacheslav O Nikolaev; Christian Meyer
Journal:  J Vis Exp       Date:  2018-05-22       Impact factor: 1.355

Review 3.  Misinterpretation of the mouse ECG: 'musing the waves of Mus musculus'.

Authors:  Bastiaan J Boukens; Mathilde R Rivaud; Stacey Rentschler; Ruben Coronel
Journal:  J Physiol       Date:  2014-09-25       Impact factor: 5.182

4.  Experimental design and analysis and their reporting: new guidance for publication in BJP.

Authors:  Michael J Curtis; Richard A Bond; Domenico Spina; Amrita Ahluwalia; Stephen P A Alexander; Mark A Giembycz; Annette Gilchrist; Daniel Hoyer; Paul A Insel; Angelo A Izzo; Andrew J Lawrence; David J MacEwan; Lawrence D F Moon; Sue Wonnacott; Arthur H Weston; John C McGrath
Journal:  Br J Pharmacol       Date:  2015-07       Impact factor: 8.739

5.  Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a cross-sectional study.

Authors:  Holger Langhof; William Wei Lim Chin; Susanne Wieschowski; Carole Federico; Jonathan Kimmelman; Daniel Strech
Journal:  Br J Pharmacol       Date:  2018-10-01       Impact factor: 8.739

6.  Effect of Lactation on myocardial vulnerability to ischemic insult in rats.

Authors:  Sahar Askari; Alireza Imani; Hamidreza Sadeghipour; Mahdieh Faghihi; Zohreh Edalatyzadeh; Samira Choopani; Nasser Karimi; Sulail Fatima
Journal:  Arq Bras Cardiol       Date:  2017-04-20       Impact factor: 2.000

7.  S1P receptor 1-Mediated Anti-Renin-Angiotensin System Cardioprotection: Pivotal Role of Mast Cell Aldehyde Dehydrogenase Type 2.

Authors:  Alice Marino; Takuya Sakamoto; Pablo A Robador; Kengo Tomita; Roberto Levi
Journal:  J Pharmacol Exp Ther       Date:  2017-05-12       Impact factor: 4.030

8.  Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia by Inhibition of Ca2+/Calmodulin-Dependent Kinase II.

Authors:  Vassilios J Bezzerides; Ana Caballero; Suya Wang; Yulan Ai; Robyn J Hylind; Fujian Lu; Danielle A Heims-Waldron; Kristina D Chambers; Donghui Zhang; Dominic J Abrams; William T Pu
Journal:  Circulation       Date:  2019-06-03       Impact factor: 29.690

9.  Electromechanical and atrial and ventricular antiarrhythmic actions of CIJ-3-2F, a novel benzyl-furoquinoline vasodilator in rat heart.

Authors:  Gwo-Jyh Chang; Yung-Hsin Yeh; Tsung-Pin Lin; Chi-Jen Chang; Wei-Jan Chen
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

10.  Feasibility of targeting ischaemia-related ventricular arrhythmias by mimicry of endogenous protection by endocannabinoids.

Authors:  Ellen Andrag; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.